18 min listen
How TwoXAR Is Using Big Data to Accelerate Drug Discovery
FromThe Bio Report
ratings:
Length:
25 minutes
Released:
Oct 27, 2016
Format:
Podcast episode
Description
It can take up to six years to accumulate enough evidence to support advancing an experimental drug into clinical development. twoXAR is working to rapidly accelerate that process through the use of Big Data and its proprietary algorithms to find screen large public and proprietary data sets to indentify new drug candidates and determine their efficacy. We spoke to Andrew Radin, co-founder and CEO of twoXAR, about the company’s technology, how it’s being applied today, and the evolution of the company’s strategy.
Released:
Oct 27, 2016
Format:
Podcast episode
Titles in the series (100)
The Power of IBM’s Watson Is Coming to an App Near You: IBM’s Watson Group recently announced an investment in Pathway Genomics, part of a $100 million initiative by the computing giant to spur innovation in entrepreneurial companies that seek to leverage its cognitive computing platform Watson. Pathway G... by The Bio Report